Skip to main content
. 2024 Mar 25;73(6):1015–1024. doi: 10.1136/gutjnl-2023-330584

Figure 4.

Figure 4

Novel targets and therapies for acute-on-chronic liver failure. The Figure illustrates novel targets and therapies that are in early development and/or phases 1 and 2 trials for acute-on-chronic liver failure. G-CSF, granulocyte colony-stimulating factor; RIPK, receptor interacting protein kinase; TLR, toll-like receptor. Created with BioRender.com with publication licence.